头颈癌质子治疗中经典与解剖鲁棒优化治疗计划对不同不确定性来源鲁棒性的量化比较
本研究对20例头颈鳞癌患者的IMPT计划比较经典鲁棒优化(cRO,仅用计划CT)与解剖鲁棒优化(aRO,额外纳入2次每周控制CT)的鲁棒性。逐步加入非刚性解剖变化、分次刚性随机摆位误差和质子射程系统误差后,cRO计划在仅考虑非刚性解剖变化时CTV覆盖下降更明显,而aRO计划对此稳健;两种计划OAR剂量变化相似。
要点
- cRO计划名义CTV覆盖更高,但仅考虑非刚性解剖变化时aRO覆盖更优。
- 低危/高危CTV的D98%中位下降:cRO为1.8/1.1个百分点,aRO为-0.2/-0.3个百分点。
- 摆位与射程误差对cRO的CTV覆盖影响更大,但两种计划OAR剂量变化相似。
核心结论
- 非刚性解剖变化是cRO计划关键靶区覆盖丢失的主要原因,而aRO方法对此类变化稳健;两种计划对OAR参数的鲁棒性相似。
研究设计与样本
- 对20例接受每周控制CT(cCT)的头颈鳞癌(HNSCC)患者优化两种IMPT计划:cRO仅使用计划CT,aRO额外纳入2次cCT。
诊断标准与关键数值
- 逐步分析三类不确定性来源的影响:每周cCT反映的非刚性解剖变化、分次添加的刚性随机摆位误差、额外系统性质子射程不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Classical robust optimization (cRO) in intensity-modulated proton therapy (IMPT) considers isocenter position and particle range uncertainties; anatomical robust optimization (aRO) aims to consider additional non-rigid positioning variations. This work compares the influence of different uncertainty sources on the robustness of cRO and aRO IMPT plans for head and neck squamous cell carcinoma (HNSCC).
METHODS: Two IMPT plans were optimized for 20 HNSCC patients who received weekly control CTs (cCT): cRO, using solely the planning CT, and aRO, including 2 additional cCTs. The robustness of the plans in terms of clinical target volume (CTV) coverage and organ at risk (OAR) sparing was analyzed considering stepwise the influence of (1) non-rigid anatomical variations given by the weekly cCT, (2) with fraction-wise added rigid random setup errors and (3) additional systematic proton range uncertainties.
RESULTS: cRO plans presented significantly higher nominal CTV coverage but are outperformed by aRO plans when considering non-rigid anatomical variations only, as cRO and aRO plans presented a median target coverage (D98%) decrease for the low-risk/high-risk CTV of 1.8/1.1 percentage points (pp) and -0.2 pp/-0.3 pp, respectively. Setup and range uncertainties had larger influence on cRO CTV coverage, but led to similar OAR dose changes in both plans. Considering all error sources, 10/2 cRO/aRO patients missed the CTV coverage and a limited number exceeded some OAR constraints in both plans.
CONCLUSION: Non-rigid anatomical variations are mainly responsible for critical target coverage loss of cRO plans, whereas the aRO approach was robust against such variations. Both plans provide similar robustness of OAR parameters.
ADVANCES IN KNOWLEDGE: The influence of different uncertainty sources was quantified for robust IMPT HNSCC plans.
引用
- Cubillos-Mesías M, Troost EGC, Lohaus F, et al. Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy. Br J Radiol. 2019. PMID: 31778315. doi:10.1259/bjr.20190573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。